Close
Nordic 9Nordic 9

STipe Therapeutics (private company)

Denmark stipetherapeutics.com
See something wrong or missing? Let us know
Offices:Aarhus
Industry:BiotechHealth servicesPharma
Business model:B2B

STipe Therapeutics is a biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer.

STipe Therapeutics went bankrupt in 2024.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 21.81M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to STipe Therapeutics

Name Criteria
Denmark NMD Pharma
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Exiscientia
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Top